Macquarie Group
MR

Macquarie Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Macquarie Group’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-261,757
Closed -$7.1M – 1655
2015
Q4 		$7.1M Buy
261,757
+13,794
+6% +$355K 0.01% 628
2015
Q3 		$5.42M Sell
247,963
-24,603
-9% -$628K 0.01% 691
2015
Q2 		$7.77M Sell
272,566
-2,400
-0.9% -$69.9K 0.02% 626
2015
Q1 		$7.52M Sell
274,966
-79,798
-22% -$2.2M 0.01% 628
2014
Q4 		$9.37M Buy
354,764
+13,378
+4% +$392K 0.02% 538
2014
Q3 		$10.3M Buy
341,386
+30,105
+10% +$932K 0.02% 495
2014
Q2 		$9.8M Buy
311,281
+15,640
+5% +$496K 0.02% 514
2014
Q1 		$9.57M Buy
295,641
+22,873
+8% +$801K 0.02% 506
2013
Q4 		$9.92M Buy
272,768
+89,768
+49% +$3.49M 0.02% 475
2013
Q3 		$7.12M Sell
183,000
-7,100
-4% -$286K 0.01% 535
2013
Q2 		$7.12M Buy
+190,100
New +$7.51M 0.02% 514

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Macquarie Group's MR Position: Q1 2016 in Review

Macquarie Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 261,757 shares — an estimated $7.1M sold.

Macquarie Group first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $10.3M in Q3 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Macquarie Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Macquarie Group sold 261,757 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $7.1M.
  • Macquarie Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Macquarie Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $10.3M in Q3 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Macquarie Group's 13F filing for Q1 2016, filed 16 May 2016.